Bicara Therapeutics Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 10/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 10/11/2025 | Jun 2024Filed 10/11/2025 | Mar 2024Filed 10/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$55 | −$56 | −$36 | −$27 | −$37 | −$17 | −$17 | −$13 | |
| −$0.82 | −$0.93 | −$0.67 | −$0.50 | −$0.68 | −$1.60 | −$19.01 | −$18.94 | |
| 68 | 61 | 55 | 55 | 54 | 11 | 0.9 | 0.7 |
Trend